SRPT
Sarepta Therapeutics Inc
$17.80
0.17 (0.95%) Today
— up— down
Market Cap
$1.90B+0.9%
Revenue (TTM)
$1.89B-2.2%
Net Income (TTM)
$7.20M
$7.20MEPS (TTM)
0.07
0.07Shares Out
105.58M
105.58MP/E Ratio
28.69
28.69Forward P/E
7.36
7.36Open
$18.23
$18.23Previous Close
$17.97
$17.97Day Range
$17.76 – $18.30
$17.76 – $18.3052-Week Range
$10.42 – $25.32
$10.42 – $25.32Beta
0.21
0.21Volume
90.17K
90.17KAvg Volume
3.20M
3.20MAnalyst Rating
Hold
HoldExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout SRPT
Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States. Incorporated in 1980 as AntiVirals, shortly before going public the company changed its name from AntiVirals to AVI BioPharma soon with stock symbol AVII and in July 2012 changed name from AVI BioPharma to Sarepta Therapeutics and SRPT respectively. As of 2023, the company has four approved drugs.